Recent studies and legislative developments indicate significant healthcare changes with potential Medicare coverage for anti-obesity medications (AOMs). The latest analysis, published on August 15, 2024, sheds light on the financial implications and benefits of incorporating a AOMs into Medicare coverage.
Benedic Ippolito, a senior...
The Biden administration released its list of 10 drugs for direct price negotiations with manufacturers. The highly anticipated list is the most recent step in enacting a part of the Inflation Reduction Act (IRA) of 2022. The drugs listed are largely treatments related to Type 2 diabetes, blood thinning, arthritis and cancer...
The new model may save the Medicare program more than $180 million by keeping beneficiaries healthy and averting new cases of diabetes.
According to CMS, Medicare spends more than $104 billion every year treating patients with this preventable disease.
The Medicare diabetes prevention program was launched in 2012 as a small,...
